Journal Article

Current insights and assumptions on α-synuclein in Lewy body disease

Hu, Xiaoming, Brodsky, Jeffrey L., Abbas, Muslim, Chen, Jun, Leak, Rehana K., Clark, Rachel N., Luk, Kelvin C., Xu, Fei

2024

Overview

Lewy body disorders are heterogeneous neurological conditions defined by intracellular inclusions composed of misshapen α-synuclein protein aggregates. Although α-synuclein aggregates are only one component of inclusions and not strictly coupled to neurodegeneration, evidence suggests they seed the propagation of Lewy pathology within and across cells. Genetic mutations, genomic multiplications, and sequence polymorphisms of the gene encoding α-synuclein are also causally linked to Lewy body disease. In nonfamilial cases of Lewy body disease, the disease trigger remains unidentified but may range from industrial/agricultural toxicants and natural sources of poisons to microbial pathogens. Perhaps due to these peripheral exposures, Lewy inclusions appear at early disease stages in brain regions connected with cranial nerves I and X, which interface with inhaled and ingested environmental elements in the nasal or gastrointestinal cavities. Irrespective of its identity, a stealthy disease trigger most likely shifts soluble α-synuclein (directly or indirectly) into insoluble, cross-β-sheet aggregates. Indeed, β-sheet-rich self-replicating α-synuclein multimers reside in patient plasma, cerebrospinal fluid, and other tissues, and can be subjected to α-synuclein seed amplification assays. Thus, clinicians should be able to capitalize on α-synuclein seed amplification assays to stratify patients into potential responders versus non-responders in future clinical trials of α-synuclein targeted therapies. Here, we briefly review the current understanding of α-synuclein in Lewy body disease and speculate on pathophysiological processes underlying the potential transmission of α-synucleinopathy across the neuraxis.

• Publisher: Springer Berlin Heidelberg,Springer Nature B.V
• Subject: alpha-Synuclein - metabolism / Animals / Brain / Brain - metabolism / Brain - pathology / Cell death / Cerebrospinal fluid / Clinical trials / Cranial nerves / Dementia / Disease transmission / Humans / Lewy bodies / Lewy Bodies - metabolism / Lewy Bodies - pathology / Lewy body disease / Lewy Body Disease - metabolism / Lewy Body Disease - pathology / Medicine / Medicine & Public Health / Mutation / Nervous system / Neuraxis / Neurodegeneration / Neurological diseases / Neurons / Neurosciences / Pathology / Patients / Proteins / Review / Synuclein / Toxicants